279 related articles for article (PubMed ID: 28606690)
1. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
Garcia HH; Del Brutto OH;
Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
[TBL] [Abstract][Full Text] [Related]
2. Cysticidal therapy: impact on seizure control in epilepsy associated with neurocysticercosis.
Santos IC; Kobayashi E; Cardoso TM; Guerreiro CA; Cendes F
Arq Neuropsiquiatr; 2000 Dec; 58(4):1014-20. PubMed ID: 11105066
[TBL] [Abstract][Full Text] [Related]
3. Anthelmintics for people with neurocysticercosis.
Monk EJM; Abba K; Ranganathan LN
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD000215. PubMed ID: 34060667
[TBL] [Abstract][Full Text] [Related]
4. Frequency and Determinant Factors for Calcification in Neurocysticercosis.
Bustos JA; Arroyo G; Gilman RH; Soto-Becerra P; Gonzales I; Saavedra H; Pretell EJ; Nash TE; O'Neal SE; Del Brutto OH; Gonzalez AE; Garcia HH;
Clin Infect Dis; 2021 Nov; 73(9):e2592-e2600. PubMed ID: 32556276
[TBL] [Abstract][Full Text] [Related]
5. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study.
Stelzle D; Makasi C; Schmidt V; Trevisan C; Van Damme I; Ruether C; Dorny P; Magnussen P; Zulu G; Mwape KE; Bottieau E; Prazeres da Costa C; Prodjinotho UF; Carabin H; Jackson E; Fleury A; Gabriël S; Ngowi BJ; Winkler AS
Infection; 2023 Aug; 51(4):1127-1139. PubMed ID: 36961623
[TBL] [Abstract][Full Text] [Related]
7. Controversies in the treatment of seizures associated with neurocysticercosis.
Singh G; Sharma R
Epilepsy Behav; 2017 Nov; 76():163-167. PubMed ID: 28673685
[TBL] [Abstract][Full Text] [Related]
8. Neurocysticercosis.
Garcia HH
Neurol Clin; 2018 Nov; 36(4):851-864. PubMed ID: 30366559
[TBL] [Abstract][Full Text] [Related]
9. TNF-α blockade suppresses pericystic inflammation following anthelmintic treatment in porcine neurocysticercosis.
Mahanty S; Orrego MA; Cangalaya C; Adrianzen MP; Arroyo G; Calcina J; Gonzalez AE; García HH; Guerra-Giraldez C; Nash TE;
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006059. PubMed ID: 29190292
[TBL] [Abstract][Full Text] [Related]
10. Antiparasitic treatment of cerebral cysticercosis: lessons and experiences from China.
Wu W; Jia F; Wang W; Huang Y; Huang Y
Parasitol Res; 2013 Aug; 112(8):2879-90. PubMed ID: 23695946
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
[TBL] [Abstract][Full Text] [Related]
12. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.
Garcia HH; Pretell EJ; Gilman RH; Martinez SM; Moulton LH; Del Brutto OH; Herrera G; Evans CA; Gonzalez AE;
N Engl J Med; 2004 Jan; 350(3):249-58. PubMed ID: 14724304
[TBL] [Abstract][Full Text] [Related]
13. Enhanced steroid dosing reduces seizures during antiparasitic treatment for cysticercosis and early after.
Garcia HH; Gonzales I; Lescano AG; Bustos JA; Pretell EJ; Saavedra H; Nash TE;
Epilepsia; 2014 Sep; 55(9):1452-9. PubMed ID: 25092547
[TBL] [Abstract][Full Text] [Related]
14. Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study.
Das K; Mondal GP; Banerjee M; Mukherjee BB; Singh OP
J Clin Neurosci; 2007 Dec; 14(12):1172-7. PubMed ID: 17964789
[TBL] [Abstract][Full Text] [Related]
15. Medical management of neurocysticercosis.
Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
[TBL] [Abstract][Full Text] [Related]
16. Neurocysticercosis: Diagnostic problems & current therapeutic strategies.
Rajshekhar V
Indian J Med Res; 2016 Sep; 144(3):319-326. PubMed ID: 28139530
[TBL] [Abstract][Full Text] [Related]
17. Optimizing therapy of seizures in patients with HIV and cysticercosis.
Bhigjee AI; Rosemberg S
Neurology; 2006 Dec; 67(12 Suppl 4):S19-22. PubMed ID: 17190916
[TBL] [Abstract][Full Text] [Related]
18. Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
Arroyo G; Bustos JA; Lescano AG; Gonzales I; Saavedra H; Rodriguez S; Pretell EJ; Bonato PS; Lanchote VL; Takayanagui OM; Horton J; Gonzalez AE; Gilman RH; Garcia HH;
Clin Infect Dis; 2019 Nov; 69(11):1996-2002. PubMed ID: 30715265
[TBL] [Abstract][Full Text] [Related]
19. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials.
Matthaiou DK; Panos G; Adamidi ES; Falagas ME
PLoS Negl Trop Dis; 2008 Mar; 2(3):e194. PubMed ID: 18335068
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
